Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome
Oana Albai,1,2 Mirela Frandes,3 Bogdan Timar,2,3 Diana-Loreta Paun,4 Deiana Roman,1 Romulus Timar1,2 1Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; 2Department of Diabetes and Metabolic Diseases, “Pius Br...
Guardado en:
Autores principales: | Albai O, Frandes M, Timar B, Paun DL, Roman D, Timar R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c28a5d6427d418f9b51493c810b66ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study
por: Gaita L, et al.
Publicado: (2019) -
Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment
por: Albai O, et al.
Publicado: (2019) -
The Mental Status in Patients with Diabetes Mellitus Admitted to a Diabetes Clinic After Presenting in the Emergency Room: The Application of the SCL-90 Scale
por: Albai O, et al.
Publicado: (2021) -
Early detection of metabolic dysregulation using water T2 analysis of biobanked samples
por: Mishra I, et al.
Publicado: (2018) -
Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
por: Albai O, et al.
Publicado: (2020)